Recalls / Active ingredient / Ertugliflozin Pidolate
Ertugliflozin Pidolate
1 FDA drug recall involving the active ingredient “Ertugliflozin Pidolate”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2021-03-15 | Class II | Steglatro (ertugliflozin) tablets 15 mg 30 Tablets Rx only NDC 0006-5364-03 Manuf. for: Merck Sharp & Dohme Co | Cardinal Health Inc. |